KRAS and cancer: Loss of YAP1 in epithelial cells also reduced the number of tumor promoting cancer‐associated fibroblasts and lymphocytes in early stage lesions, suggesting that YAP1 influences KRAS‐mediated tumor progression through multiple mechanisms.